We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$282M
Cap. Flow
+$321M
Cap. Flow %
15.28%
Top 10 Hldgs %
31.03%
Holding
185
New
43
Increased
48
Reduced
68
Closed
26

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$37.3M
2
SON icon
Sonoco
SON
+$27.1M
3
MTCH icon
Match Group
MTCH
+$24.8M
4
PLD icon
Prologis
PLD
+$23.9M
5
SLB icon
SLB Ltd
SLB
+$19.3M

Top Sells

Rank Stock Value
1
MTB icon
M&T Bank
MTB
+$36.8M
2
ZM icon
Zoom
ZM
+$25.3M
3
WBD icon
Warner Bros
WBD
+$23.6M
4
LYFT icon
Lyft
LYFT
+$22.3M
5
EXPE icon
Expedia Group
EXPE
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Consumer Discretionary 13.65%
3 Healthcare 10.33%
4 Communication Services 7.49%
5 Consumer Staples 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOMO icon
151
Domo
DOMO
$189M
$1.56M 0.07%
220,475
-35,580
-14% -$288K
BOOM icon
152
DMC Global
BOOM
$153M
$1.44M 0.07%
+196,289
New +$1.85M
TBRG
153
DELISTED
TruBridge
TBRG
$1.43M 0.07%
72,483
-125,191
-63% -$1.93M
JOUT icon
154
Johnson Outdoors
JOUT
$501M
$1.42M 0.07%
43,148
-6,916
-14% -$235K
VPG icon
155
Vishay Precision Group
VPG
$864M
$1.23M 0.06%
+52,373
New +$1.23M
RIVN icon
156
Rivian
RIVN
$23.7B
$940K 0.04%
70,688
-11,324
-14% -$130K
LEXX icon
157
Lexaria Bioscience
LEXX
$9.07M
$863K 0.04%
27,382
-4,336
-14% -$160K
PETS icon
158
PetMed Express
PETS
$42.1M
$715K 0.03%
148,422
-24,231
-14% -$114K
PRPL icon
159
Purple Innovation
PRPL
$39.6M
$620K 0.03%
+31,807
New +$720K
ASTL icon
160
Algoma Steel
ASTL
$468M
– –
-636,917
Closed -$6.52M
AVA icon
161
Avista
AVA
$3.2B
– –
-275,741
Closed -$10.7M
BABA icon
162
Alibaba
BABA
$317B
– –
-40,155
Closed -$4.26M
CMTL icon
163
Comtech Telecommunications
CMTL
$51.5M
– –
-731,168
Closed -$3.52M
COP icon
164
ConocoPhillips
COP
$148B
– –
-92,840
Closed -$9.77M
CPRI icon
165
Capri Holdings
CPRI
$1.75B
– –
-99,430
Closed -$4.22M
CRM icon
166
Salesforce
CRM
$162B
– –
-39,250
Closed -$10.7M
DAL icon
167
Delta Air Lines
DAL
$58.7B
– –
-64,465
Closed -$3.27M
DOCU
168
DocuSign
DOCU
$11.4B
– –
-112,189
Closed -$6.97M
EPD icon
169
Enterprise Products Partners
EPD
$82.2B
– –
-121,441
Closed -$3.54M
FVRR icon
170
Fiverr
FVRR
$327M
– –
-479,382
Closed -$12.4M
ILMN icon
171
Illumina
ILMN
$29B
– –
-48,224
Closed -$6.29M
INMD icon
172
InMode
INMD
$873M
– –
-165,502
Closed -$2.81M
LYFT icon
173
CALL
Lyft
LYFT
$6.55B
– –
-650,000
Closed -$8.29M
MD icon
174
Pediatrix Medical
MD
$2.12B
– –
-780,983
Closed -$9.05M
MITK icon
175
Mitek Systems
MITK
$837M
– –
-469,177
Closed -$4.07M
4 5 6
7
8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Invenomic Capital Management held 185 positions worth $2.1B, up 15% from $1.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Invenomic Capital Management deployed $321M of net new capital in Q4 2024, opening 43 new positions and adding to 48 existing holdings. Its largest new stake was Prologis: 207,979 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was M&T Bank, an estimated $36.8M trimmed.

  • Invenomic Capital Management's largest Q4 2024 buy was Prologis: 207,979 shares worth $22M.
  • Invenomic Capital Management added most to Dentsply Sirona in Q4 2024, an estimated $37.3M increase.
  • Invenomic Capital Management's biggest Q4 2024 reduction was M&T Bank, cutting an estimated $36.8M.
  • Invenomic Capital Management fully exited Warner Bros in Q4 2024, selling an estimated $23.6M.
  • Invenomic Capital Management's ten largest holdings make up 31% of its $2.1B portfolio in Q4 2024.
  • Invenomic Capital Management opened 43 new positions and closed 26 in Q4 2024.
  • Invenomic Capital Management's portfolio value rose 15% quarter-over-quarter to $2.1B.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.